Background Atopic eczema (AE) may be associated with several mental health problems. In
Germany, existing data from selected patient cohorts may lead to misestimation of the …

Background Atopic dermatitis (AD) has far‐reaching consequences in childhood and later in
working life, but information on how it affects completion of education is sparse. Objectives …

Assessment of atopic dermatitis (AD) severity is essential for therapeutic decision making
and monitoring treatment progress. However, there are a myriad of clinical measurement …

Janus kinase inhibitors, also known as JAK inhibitors, JAKinibs or JAKi, are a new group of
disease-modifying drugs. They work by inhibiting enzymes involved in the transmission of …

Background Atopic dermatitis (AD) is a complex disease with variations in severity and
healthcare utilization. Examining patient pathways through analyses of longitudinal patient …

Significance: Cutaneous wounds are a major problem in both human and equine medicine.
The economic cost of treating skin wounds and related complications in humans and horses …

Background There is a wide range in the reported prevalences of depression in patients with
systemic lupus erythematosus (SLE), while the prevalence of depression in patients with …

Atopic dermatitis (AD) is a common disease clinically characterized by chronic recurrent
eczematous lesions, dry skin, and pruritus. AD can negatively impact patients' quality of life …

Introduction Atopic dermatitis (AD) is an inflammatory skin disease with a chronic, relapsing
course. Clinical features of AD vary by age, duration, and severity but can include papules …

Background Eczematous skin diseases, eg, atopic dermatitis or contact dermatitis, are
associated with a high disease burden, a significant impact on quality of life and a higher …